Skip to main content
. 2021 May 28;12:663743. doi: 10.3389/fphar.2021.663743

FIGURE 4.

FIGURE 4

The absorption-promoting effects of benzaldehyde for acyclovir (ACV) and hydrochlorothiazide (HTZ) in vivo. (A) Mean plasma concentration–time profile of acyclovir with or without benzaldehyde. (●) Control group (acyclovir 5 mg/kg), (■) 140 mg/kg benzaldehyde (acyclovir 5 mg/kg). (B) Mean plasma concentration–time profile of hydrochlorothiazide with or without benzaldehyde. (●) Control group (hydrochlorothiazide 17 mg/kg), (■) 140 mg/kg benzaldehyde (hydrochlorothiazide 17 mg/kg).